Related references
Note: Only part of the references are listed.Reduced expression but not deficiency of GFI1 causes a fatal myeloproliferative disease in mice
Jennifer Fraszczak et al.
LEUKEMIA (2019)
B1 oligomerization regulates PML nuclear body biogenesis and leukemogenesis
Yuwen Li et al.
NATURE COMMUNICATIONS (2019)
The SIN3A histone deacetylase complex is required for a complete transcriptional response to hypoxia
Maria Tiana et al.
NUCLEIC ACIDS RESEARCH (2018)
GFI1 is required for RUNX1/ETO positive acute myeloid leukemia
Anna E. Marneth et al.
HAEMATOLOGICA (2018)
RING tetramerization is required for nuclear body biogenesis and PML sumoylation
Pengran Wang et al.
NATURE COMMUNICATIONS (2018)
GFI1 is required for RUNX1/ETO positive acute myeloid leukemia
Anna E. Marneth et al.
HAEMATOLOGICA (2018)
HDAC stimulates gene expression through BRD4 availability in response to IFN and in interferonopathies
Isabelle J. Marie et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
AML associated oncofusion proteins PML-RARA, AML1-ETO and CBFB-MYH11 target RUNX/ETS-factor binding sites to modulate H3ac levels and drive leukemogenesis
Abhishek A. Singh et al.
ONCOTARGET (2017)
Enforced GFI1 expression impedes human and murine leukemic cell growth
Judith M. Hoenes et al.
SCIENTIFIC REPORTS (2017)
Gene Essentiality Profiling Reveals Gene Networks and Synthetic Lethal Interactions with Oncogenic Ras
Tim Wang et al.
CELL (2017)
GFI1 proteins orchestrate the emergence of haematopoietic stem cells through recruitment of LSD1
Roshana Thambyrajah et al.
NATURE CELL BIOLOGY (2016)
BloodSpot: a database of gene expression profiles and transcriptional programs for healthy and malignant haematopoiesis
Frederik Otzen Bagger et al.
NUCLEIC ACIDS RESEARCH (2016)
GFI1 functions in transcriptional control and cell fate determination require SNAG domain methylation to recruit LSD1
Matthew Velinder et al.
BIOCHEMICAL JOURNAL (2016)
GFI1 as a novel prognostic and therapeutic factor for AML/MDS
J. M. Hoenes et al.
LEUKEMIA (2016)
LSD1 engages a corepressor complex for the activation of the estrogen receptor α by estrogen and cAMP
Marcela A. Bennesch et al.
NUCLEIC ACIDS RESEARCH (2016)
Histone Deacetylases Positively Regulate Transcription through the Elongation Machinery
Celeste B. Greer et al.
CELL REPORTS (2015)
Comparing cancer vs normal gene expression profiles identifies new disease entities and common transcriptional programs in AML patients
Nicolas Rapin et al.
BLOOD (2014)
Targeting Transcriptional Addictions in Small Cell Lung Cancer with a Covalent CDK7 Inhibitor
Camilla L. Christensen et al.
CANCER CELL (2014)
HIF factors cooperate with PML-RARa to promote acute promyelocytic leukemia progression and relapse
Nadia Coltella et al.
EMBO MOLECULAR MEDICINE (2014)
Chromatin modifiers and remodellers: regulators of cellular differentiation
Taiping Chen et al.
NATURE REVIEWS GENETICS (2014)
Coordinated regulation of the immunoproteasome subunits by PML/RARα and PU.1 in acute promyelocytic leukemia
X-W Yang et al.
ONCOGENE (2014)
Growth Factor Independence 1 Antagonizes a p53-Induced DNA Damage Response Pathway in Lymphoblastic Leukemia
Cyrus Khandanpour et al.
CANCER CELL (2013)
Super-Enhancers in the Control of Cell Identity and Disease
Denes Hnisz et al.
CELL (2013)
CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes
Luke A. Gilbert et al.
CELL (2013)
Uncoupling RARA transcriptional activation and degradation clarifies the bases for APL response to therapies
Julien Ablain et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Tracking the extramedullary PML-RARα-positive cell reservoirs in a preclinical model: Biomarker of long-term drug efficacy
Katerina Pokorna et al.
MOLECULAR AND CELLULAR PROBES (2013)
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
Timothy J. Ley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Chromatin accessibility, p300, and histone acetylation define PML-RARα and AML1-ETO binding sites in acute myeloid leukemia
Sadia Saeed et al.
BLOOD (2012)
ERG and FLI1 binding sites demarcate targets for aberrant epigenetic regulation by AML1-ETO in acute myeloid leukemia
Joost H. A. Martens et al.
BLOOD (2012)
Expression and Function of PML-RARA in the Hematopoietic Progenitor Cells of Ctsg-PML-RARA Mice
Lukas D. Wartman et al.
PLOS ONE (2012)
edgeR: a Bioconductor package for differential expression analysis of digital gene expression data
Mark D. Robinson et al.
BIOINFORMATICS (2010)
PML/RARα Targets Promoter Regions Containing PU.1 Consensus and RARE Half Sites in Acute Promyelocytic Leukemia
Kankan Wang et al.
CANCER CELL (2010)
PML-RARα/RXR Alters the Epigenetic Landscape in Acute Promyelocytic Leukemia
Joost H. A. Martens et al.
CANCER CELL (2010)
PML/RARA Oxidation and Arsenic Binding Initiate the Antileukemia Response of As2O3
Marion Jeanne et al.
CANCER CELL (2010)
c-Myc Regulates Transcriptional Pause Release
Peter B. Rahl et al.
CELL (2010)
Molecular genetics in acute myeloid leukemia
Ulrike Bacher et al.
CURRENT OPINION IN ONCOLOGY (2010)
Gfi1 and Gfi1b: key regulators of hematopoiesis
L. T. van der Meer et al.
LEUKEMIA (2010)
Deconstructing repression: evolving models of co-repressor action
Valentina Perissi et al.
NATURE REVIEWS GENETICS (2010)
PML/RARα fusion protein transactivates the tissue factor promoter through a GAGC-containing element without direct DNA association
Jinsong Yan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Arsenic Trioxide Controls the Fate of the PML-RARα Oncoprotein by Directly Binding PML
Xiao-Wei Zhang et al.
SCIENCE (2010)
Acute promyelocytic leukaemia: novel insights into the mechanisms of cure
Hugues de The et al.
NATURE REVIEWS CANCER (2010)
Gfi1 integrates progenitor versus granulocytic transcriptional programming
Shane R. Horman et al.
BLOOD (2009)
Genome-wide Mapping of HATs and HDACs Reveals Distinct Functions in Active and Inactive Genes
Zhibin Wang et al.
CELL (2009)
High throughput digital quantification of mRNA abundance in primary human acute myeloid leukemia samples
Jacqueline E. Payton et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Acute promyelocytic leukemia: from highly fatal to highly curable
Zhen-Yi Wang et al.
BLOOD (2008)
Acetylation of PML is involved in histone deacetylase inhibitor-mediated apoptosis
Fumihiko Hayakawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation
Rihab Nasr et al.
NATURE MEDICINE (2008)
Model-based Analysis of ChIP-Seq (MACS)
Yong Zhang et al.
GENOME BIOLOGY (2008)
An evaluation of 3C-based methods to capture DNA interactions
Marieke Simonis et al.
NATURE METHODS (2007)
PML-retinoic acid receptor α inhibits PML IV enhancement of PU.1-induced C/EBPFε expression in myeloid differentiation
Hitoshi Yoshida et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
The complex language of chromatin regulation during transcription
Shelley L. Berger
NATURE (2007)
Gfi1b:: green fluorescent protein knock-in mice reveal a dynamic expression pattern of Gfi1b during hematopoiesis that is largely complementary to Gfi1
Lothar Vassen et al.
BLOOD (2007)
Histone H3 methylation by Set2 directs deacetylation of coding regions by Rpd3S to suppress spurious intragenic transcription
MJ Carrozza et al.
CELL (2005)
c-Myc rapidly induces acute myeloid leukemia in mice without evidence of lymphoma-associated antiapoptotic mutations
H Luo et al.
BLOOD (2005)
Gfi-1 restricts proliferation and preserves functional integrity of haematopoietic stem cells
H Hock et al.
NATURE (2004)
Comparative analysis of genes regulated by PML/RARα and PLZF/RARα response to retinoic acid using oligonucleotide arrays
DJ Park et al.
BLOOD (2003)
Intrinsic requirement for zinc finger transcription factor Gfi-1 in neutrophil differentiation
H Hock et al.
IMMUNITY (2003)
Inflammatory reactions and severe neutropenia in mice lacking the transcriptional repressor Gfi1
H Karsunky et al.
NATURE GENETICS (2002)
Share Paper
